Interleukin Il 1 | List of Frontiers open access articles

Perspective

Published on 19 Jul 2022

Innate immune activation as cofactor in pemphigus disease manifestation

in Autoimmune and Autoinflammatory Disorders

Ramona A. Eichkorn
Morna F. Schmidt
Elias Walter
Michael Hertl
Jens Malte Baron
Jens Waschke
Amir S. Yazdi

Frontiers in Immunology

doi 10.3389/fimmu.2022.898819

3,858 views
4 citations

Mini Review

Published on 26 Sep 2022

Soluble ST2 in coronary artery disease: Clinical biomarkers and treatment guidance

in Coronary Artery Disease

Junyan Zhang
Zhongxiu Chen
Min Ma
Yong He

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.924461

8,786 views
35 citations

Mini Review

Published on 11 Sep 2024

The role of inflammasomes as central inflammatory hubs in Mycobacterium tuberculosis infection

in Microbial Immunology

Sebastian J. Theobald
Tony A. Müller
Dinah Lange
Katharina Keck
Jan Rybniker

Frontiers in Immunology

doi 10.3389/fimmu.2024.1436676

5,761 views
7 citations

Review

Published on 18 Dec 2020

Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic

in Experimental Pharmacology and Drug Discovery

Giulio Cavalli
Nicola Farina
Corrado Campochiaro
Giacomo De Luca
Emanuel Della-Torre
Alessandro Tomelleri
Lorenzo Dagna

Frontiers in Pharmacology

doi 10.3389/fphar.2020.598308

7,003 views
33 citations

Review

Published on 06 Dec 2016

IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis

in Inflammation Pharmacology

Gabriella Giancane
Francesca Minoia
Sergio Davì
Giulia Bracciolini
Alessandro Consolaro
Angelo Ravelli

Frontiers in Pharmacology

doi 10.3389/fphar.2016.00467

11,390 views
52 citations

Review

Published on 16 Mar 2021

IL-1 Family Antagonists in Mouse and Human Skin Inflammation

in Cytokines and Soluble Mediators in Immunity

Praxedis Martin
Jérémie D. Goldstein
Loïc Mermoud
Alejandro Diaz-Barreiro
Gaby Palmer

Frontiers in Immunology

doi 10.3389/fimmu.2021.652846

19,578 views
79 citations

Mini Review

Published on 21 Sep 2018

Development and Role in Therapy of Canakinumab in Adult-Onset Still’s Disease

in Inflammation Pharmacology

Paola Galozzi
Chiara Baggio
Sara Bindoli
Francesca Oliviero
Paolo Sfriso

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01074

9,096 views
18 citations

Case Report

Published on 29 Oct 2021

Kidney Involvement in PSTPIP1 Associated Inflammatory Diseases (PAID): A Case Report and Review of the Literature

in Nephrology

Paola Borgia
Riccardo Papa
Matteo D'Alessandro
Roberta Caorsi
Giorgio Piaggio
Andrea Angeletti
Isabella Ceccherini
Gian Marco Ghiggeri
Marco Gattorno

Frontiers in Medicine

doi 10.3389/fmed.2021.759092

5,483 views
11 citations

Review

Published on 04 Nov 2022

Growth stimulation expressed gene 2 (ST2): Clinical research and application in the cardiovascular related diseases

in Heart Failure and Transplantation

Jinchao Chen
Peng Xiao
Dan Song
Dewei Song
Zhi Chen
Hongmei Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1007450

7,206 views
15 citations

Mini Review

Published on 13 Mar 2023

The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation

in Neonatology

Josephine C. Owen
Steven P. Garrick
Briana M. Peterson
Philip J. Berger
Marcel F. Nold
Arvind Sehgal
Claudia A. Nold-Petry

Frontiers in Pediatrics

doi 10.3389/fped.2023.1130013

6,753 views
13 citations

Review

Published on 06 Feb 2015

Interleukin-1 and acute brain injury

in Cellular Neuropathology

Katie N. Murray
Adrian R. Parry-Jones
Stuart M. Allan

Frontiers in Cellular Neuroscience

doi 10.3389/fncel.2015.00018

27,739 views
149 citations

Case Report

Published on 03 Aug 2021

X-Linked Lymphoproliferative Disease Mimicking Multisystem Inflammatory Syndrome in Children—A Case Report

in Pediatric Immunology

Seraina Prader
Nicole Ritz
Frédéric Baleydier
Maya C. Andre
Noémie Stähli
Kevin Schmid
Hanna Schmid
Andreas Woerner
Tamara Diesch
Patrick M. Meyer Sauteur

Frontiers in Pediatrics

doi 10.3389/fped.2021.691024

6,679 views
8 citations

Original Research

Published on 09 Nov 2021

Targeting TBK1 Attenuates LPS-Induced NLRP3 Inflammasome Activation by Regulating of mTORC1 Pathways in Trophoblasts

in Inflammation

Sohee Lee
Jiha Shin
Jong-Seok Kim
Jongdae Shin
Sung Ki Lee
Hwan-Woo Park

Frontiers in Immunology

doi 10.3389/fimmu.2021.743700

9,314 views
37 citations

Mini Review

Published on 11 Aug 2022

Revisiting the role of IL-1 signaling in the development of apical periodontitis

in Endodontics

Kento Tazawa
Mariane Maffei Azuma Presse
Hisako Furusho
Philip Stashenko
Hajime Sasaki

Frontiers in Dental Medicine

doi 10.3389/fdmed.2022.985558

5,025 views
22 citations

Original Research

Published on 29 Apr 2021

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation

in Viral Immunology

Emanuel Della-Torre
Marco Lanzillotta
Corrado Campochiaro
Giulio Cavalli
Giacomo De Luca
Alessandro Tomelleri
Nicola Boffini
Rebecca De Lorenzo
Annalisa Ruggeri
Patrizia Rovere-Querini

Frontiers in Immunology

doi 10.3389/fimmu.2021.675678

6,846 views
49 citations

Case Report

Published on 04 Apr 2025

Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy

in Cancer Immunity and Immunotherapy

Beatrice Manghisi
Giulia Cotilli
Marilena Fedele
Paola Perfetti
Elisabetta Terruzzi
Luisa Verga
Lorenza Maria Borin
Andrea Carrer
Monica Fumagalli
Maria Beatrice Ferrari

Frontiers in Immunology

doi 10.3389/fimmu.2025.1563736

8,353 views
5 citations

Articles

Innate immune activation as cofactor in pemphigus disease manifestation

Soluble ST2 in coronary artery disease: Clinical biomarkers and treatment guidance

The role of inflammasomes as central inflammatory hubs in Mycobacterium tuberculosis infection

Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic

IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis

IL-1 Family Antagonists in Mouse and Human Skin Inflammation

Development and Role in Therapy of Canakinumab in Adult-Onset Still’s Disease

Kidney Involvement in PSTPIP1 Associated Inflammatory Diseases (PAID): A Case Report and Review of the Literature

Growth stimulation expressed gene 2 (ST2): Clinical research and application in the cardiovascular related diseases

The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation

Interleukin-1 and acute brain injury

X-Linked Lymphoproliferative Disease Mimicking Multisystem Inflammatory Syndrome in Children—A Case Report

Targeting TBK1 Attenuates LPS-Induced NLRP3 Inflammasome Activation by Regulating of mTORC1 Pathways in Trophoblasts

Revisiting the role of IL-1 signaling in the development of apical periodontitis

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation

Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy